SCHEMBL20343593

SCHEMBL20343593

CCC(=O)N1CC2CCCC2C1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.62
CHRNA3 P32297 5/20 0.62
CHRNA4 P43681 5/20 0.62
CHRNB4 P30926 3/20 0.62
CHRNA7 P36544 3/20 0.62
CHRNB3 Q05901 2/20 0.53
CHRNA6 Q15825 2/20 0.53
HSD11B1 P28845 2/20 0.45
EPHX2 P34913 4/20 0.43
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
LMNA P02545 1/20 0.35
EPHX1 P07099 1/20 0.35
BLM P54132 1/20 0.34
JAK1 P23458 1/20 0.34
JAK3 P52333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23343819 0.96 CHRNB2 (0.62) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL21765914 0.86 CHRNB2 (0.72) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL21765915 0.86 CHRNB2 (0.72) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL20343448 0.83 CHRNB2 (0.56) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL15932468 0.82 CHRNB2 (0.67) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL20343499 0.80 HSD11B1 (0.47) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL20343378 0.80 HSD11B1 (0.47) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL18909242 0.79 CHRNB2 (0.53) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL11773423 0.78 CHRNB2 (0.62) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7
SCHEMBL4436959 0.78 ALDH1A1 (0.52) CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2023-01-19 US disclosed
US-11001575-B1 Benzolactam compounds as protein kinase inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2021-05-11 US disclosed
EP-2796460-B1 PYRROLE SIX-MEMBERED HETEROARYL RING DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICINAL USES THEREOF JIANGSU HENGRUI MEDICINE CO (CN) 2018-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS MAPK1, ALK, MAP3K1 CHRNB2 2185/4885CHRNA3 1888/4885CHRNA4 1990/4885
US-11001575-B1 Benzolactam compounds as protein kinase inhibitors MAPK1, ALK, MAP3K1 CHRNB2 2249/4885CHRNA3 1896/4885CHRNA4 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.